✦ LIBER ✦

THE PROGNOSTIC VALUE OF HER-2/NEU EXPRESSION IN COLORECTAL CANCER

✍ Scribed by Apostolos Pappas; Emmanuel Lagoudianakis; Anastasia Kaperoni; Konstantinos Toutouzas; Euaggelos Tsiampas; Artemisia Papadima; Vasiliki Drantaki; Athanasios Panoutsopoulos; Ioannis Manouras; Andreas Manouras

Book ID: 117646374
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 169 KB
Volume: 22
Category: Article
ISSN: 0953-6205
DOI: 10.1016/s0953-6205(11)60186-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HER 2/neu protein expression in colorect

HER 2/neu protein expression in colorectal cancer

✍ B Schuell; T Gruenberger; W Scheithauer; Ch Zielinski; F Wrba 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 242 KB

Prognostic significance of HER2/neu expr

Prognostic significance of HER2/neu expression in gastric cancer

✍ Julian Ananiev; Maya Gulubova; Irena Manolova; Georgi Tchernev 📂 Article 📅 2011 🏛 Springer Vienna 🌐 English ⚖ 586 KB

Prognostic value of HER-2/neu and p53 ex

Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment

✍ M.A. Climent; M.A. Seguı́; G. Peiró; R. Molina; E. Lerma; B. Ojeda; J.J. López-L 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 219 KB

HER-2/neu overexpression is an independe

HER-2/neu overexpression is an independent prognostic factor in colorectal cancer

✍ Dong Il Park; Mun Su Kang; Suk Joong Oh; Hong Joo Kim; Yong Kyun Cho; Chong Il S 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 267 KB

Prognostic value of immunohistochemicall

Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer

✍ P. Kohlberger; A. Loesch; H. Koelbl; G. Breitenecker; Ch. Kainz; G. Gitsch 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 339 KB

Prognostic and predictive value of HER2/

Prognostic and predictive value of HER2/neu oncogene in breast cancer

✍ Shahla Masood; Marilyn M. Bui 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

## Abstract Assessment of __HER2/neu__ oncogene has been used as both a prognostic and predictive marker for breast cancer. However, the choice of the best method to assess the status of __HER2/neu__ oncogene in breast cancer tissue remains controversial. A variety of techniques are available to de